Read + Share
Amedeo Smart
Independent Medical Education
Innocenti T, Roselli J, Lynch EN, Apolito P, et al. Infectious risk of vedolizumab compared with other biological agents in the treatment of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2021;33.PMID: 35048649
Email
LinkedIn
Facebook
Twitter
Privacy Policy